Possible Manchin presidential bid - Iran's morality police return - Grain deal ends

Source: Associated Press

1. Summary
   Speculation that Sen. Joe Manchin (D-WV) will run for president increased Monday after the senator appeared at a New Hampshire town hall sponsored by the centrist advocacy group No Labels. At the event, Manchin said the two big parties have "gone too far right and too far left," and that the parties needed to be threatened by a third-party push that unites centrists and independents.
   
   No Labels is seeking to get on ballots throughout the country, though its leaders say it does not intend to act as a spoiler. Many observers note the group's platform lacks specifics, such as on abortion policy.
   
   Manchin is facing a reelection challenge from Gov. Jim Justice, a Republican with a strong polling lead. Pollster Fernand Amandi told Vox that Manchin may be flirting with a presidential bid to convince the state's conservative voters that he is not subservient to Democrats. Several Democrats in West Virginia's state legislature, interviewed by the Daily Caller, had mixed opinions about whether he would run for president.

   Highly-rated - last 48 hrs
   Manchin provides little 2024 insight at No Labels New Hampshire town hall.
   Roll Call (Center) • Factual Grade 74% • 4 min read
   

1. Different political viewpoint
   Here's what West Virginia Dems think of Joe Manchin's political future in 2024.
   Daily Caller (Right) • Factual Grade 61% • 6 min read

1. Selected long-read
   Could a third-party candidate actually derail Biden?
   Vox (Left) • Factual Grade 80% • 5 min read

Russia on Monday announced it was withdrawing from the Black Sea Grain Initiative, a deal brokered last year that allowed Ukrainian and Russian agr...

Full summaries, images, and headlines for subscribers only.
One payment. Once a year. $25

Upgrade Now

On Sunday Iranian police spokesperson Saeed Montazerul-Mahdi said the country will resume 'morality police' patrols aimed at enforcing laws on women wearing headscarves. Such patrols...

Full summaries, images, and headlines for subscribers only.
Free your time. Get rid of multiple news feeds.

Upgrade Now

Eli Lilly on Monday published new clinical trial results for its Alzheimer's treatment donanemab. The drug slowed the progression of Alzheimer's by 35% in a group of 1,700 pa...

Full summaries, images, and headlines for subscribers only.
Just the facts. Just about $2/mth.

Upgrade Now